This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Boyd, K. J Articles by Kelly, M. Search for Related Content PubMed PubMed Citation Articles by Boyd, K. J Articles by Kelly, M. Social Bookmarking                   What's this?

Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer

St Christopher's Hospice, London

Moira Kelly

St Christopher's Hospice, London

We report an open, uncontrolled study to evaluate the effectiveness of regular oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer receiving standard clinical care. Fifteen patients were assessed initially, and then 48 h and 7-10 days after starting treatment with oral morphine or having their dose increased. Dyspnoea, measured on a visual analogue scale (0-100), fell by a median of 14 (95% confidence interval -1.5, 25.5; Wilcoxon statistic 32.0; P = 0.06) in the nine who completed all three assessments. The three patients who died during the study did not show symptomatic benefit and, like the three who withdrew, experienced increased sedation and/or dizziness. Sedation was significantly increased at 48 h; median rise 10.5 (95% confidence interval 7, 25; Wilcoxon statistic 74; P = 0.007). Baseline respiratory function (FEV ₁, FVC, peak flow) was poor and the patients' respiratory rate was unaffected. Regular, titrated oral morphine may improve dyspnoea in some patients with advanced cancer but can cause significant short-term adverse effects. Oral morphine should be given to these patients as a therapeutic trial. Patients should be advised about side-effects and carefully monitored. Larger studies are needed to establish which patients are most likely to benefit and optimal dosage regimens.

Key Words: dyspnoea • morphine • neoplasms • palliative treatment

Palliative Medicine, Vol. 11, No. 4, 277-281 (1997)
DOI: 10.1177/026921639701100403


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. A. Kvale, P. A. Selecky, and U. B. S. Prakash Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 368S - 403S. [Abstract] [Full Text] [PDF]

				R. George and C. Regnard Lethal opioids or dangerous prescribers? Palliative Medicine, March 1, 2007; 21(2): 77 - 80. [PDF]

				S. B. LeGrand, E. A. Khawam, D. Walsh, and N. I. Rivera Opioids, respiratory function, and dyspnea American Journal of Hospice and Palliative Medicine, January 1, 2003; 20(1): 57 - 61. [Abstract] [PDF]

				P. A. Kvale, M. Simoff, and U. B. S. Prakash Palliative Care Chest, January 1, 2003; 123(1_suppl): 284S - 311S. [Abstract] [Full Text] [PDF]

				G. A. Silvestri, C. Sherman, T. Williams, S.-S. Leong, P. Flume, and A. Turrisi Caring for the Dying Patient With Lung Cancer* Chest, September 1, 2002; 122(3): 1028 - 1036. [Full Text] [PDF]

				M Barnett Alternative opioids to morphine in palliative care: a review of current practice and evidence Postgrad. Med. J., June 1, 2001; 77(908): 371 - 378. [Full Text]

				N. Sarhill, D. Walsh, E. Khawam, P. Tropiano, and M. K. Stahley Nebulized hydromorphone for dyspnea in hospice care of advanced cancer American Journal of Hospice and Palliative Medicine, November 1, 2000; 17(6): 389 - 391. [Abstract] [PDF]

				L. Heyse-Moore, T. Beynon, and V. Ross Does spirometry predict dyspnoea in advanced cancer? Palliative Medicine, April 1, 2000; 14(3): 189 - 195. [Abstract] [PDF]

				G. Zeppetella The palliation of dyspnea in terminal disease American Journal of Hospice and Palliative Medicine, November 1, 1998; 15(6): 322 - 330. [Abstract] [PDF]